Insmed, Inc. (INSM)
159.21
-4.25
(-2.60%)
USD |
NASDAQ |
Jan 15, 16:00
159.21
0.00 (0.00%)
After-Hours: 16:45
Insmed SG&A Expense (TTM): 631.20M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Biogen, Inc. | 2.431B |
| Pfizer Inc. | 13.91B |
| Merck & Co., Inc. | 10.70B |
| CorMedix, Inc. | 75.56M |